Study cohort study 2 3 4 1 5 6 N 610 108 83 74 100 279/ 1310 85   139 Sex f (p) f f m f (p) f (p) f f/m Time 2006-7 2007 2012 2001 2007 2007-8 2002 Country GER MEX ITA TWN FRA USA GER Value Med. GM GM Med. Med. GM Med. Conc. µg/g µg/g µg/g µg/g µg/g µg/g µg/g PhthalateMetabolite MEP 48.6[3.1-1944] 83.2 77.1 56.4 / 34.3 106 73.3 MiBP 65.6 [15.9-1928] 8.4 / / 15.2 68.7 8.18 / MnBP 105.4 [21.4-6294] 72.4 20.3 17.6 87.5 45.5 23.1 157                   MCPrP 1.45 [0.24-241.30] 3.91 / / / / / / MBzP 6.70 [0.45-124] 4.37 14.7 16.4 2.07 13.6 8.07 17.2 MEHP 7.8 [1.4-360.4] 5.2 3.4 2.8 10.8 16.4 17.9 3.02 9.2                   MEHHP 13.41 [1.42-1416] 45.84 12.7/ / 32.2 44.4 25.2 40.2                   MEOHP 9.7[ 1.0-1007] 31.8 / / 29.5 32.9 14.2 30.4                   MECPP 12.1 [2.1-661] 71.9 / / 44.7 58.1 38.7 /

Table 3: Comparison of median (Med.) or geometric mean (GM) of phthalate concentrations from the cohort study with respective data from other publications. Values indicating concentration ranges are shown in brackets; values shown in gray (study [1]) refer to a sub-sample of the cohort. N: number of samples in cohort; Sex: female (f) or male (m) study participants, (p): pregnant; Time: year of sampling; Conc.: concentrations referring to creatinine mass (μg/g). Metabolites are grouped with respect to their different parent compounds (DEP, DnBP, DiBP, BBzP and DEHP).